Quantcast
Channel: ConsumerAffairs News: Class Action and Legal News
Viewing all articles
Browse latest Browse all 707

Judge throws out Perdue Pharma opioid settlement

$
0
0

A court agreed with state officials who said the agreement was too lenient

By Mark Huffman of ConsumerAffairs
December 17, 2021

Opioids and gavelA U.S. District Court judge in New York has voided a $4.5 billion opioid settlement with Perdue Pharma, handing victory to plaintiffs who contend that the settlement is too lenient.

Judge Colleen McMahons ruling, however, is technical in nature. She found that the settlements provision that shielded members of the Sackler family major Perdue shareholders is not allowed under U.S. bankruptcy law.

The settlement proposed by Perdue earlier this year increased its payout to states affected by the opioid crisis from $3 billion to more than $4 billion. Massachusetts Attorney General Maura Healey, representing one of the plaintiff states, was initially unimpressed with the new offer. She said she and several other state attorneys general planned to keep fighting, and it was their court challenge that overturned the settlement.

Several other attorneys general who signed onto the lawsuit concurred, saying they want the Sacklers to pay more of their personal funds in any settlement. "This plan does not go as far as it needs to," said North Carolina Attorney General Josh Stein in response to the proposed settlement.

Protected family members from damage claims

Specifically, the proposed settlement provided members of the Sackler with releases against civil lawsuits over the companys marketing of opioid painkillers. If approved, the settlement would have barred states that did not accept the settlement from further legal action.

Perdue Pharma entered Chapter 11 bankruptcy in 2019 and pursued a settlement as a way to emerge from bankruptcy. When it entered Chapter 11 status, it proposed a plan that it said would produce $10 billion to $12 billion to reimburse municipalities for the money theyve spent to deal with the opioid crisis.

The latest ruling means the Perdue Pharma saga isnt over yet. Judge McMahon told the Wall Street Journal that her ruling probably isnt the last word on the subject since the company is likely to appeal.

It must be put to rest sometime; at least in this Circuit, it should be put to rest now, she said.


Viewing all articles
Browse latest Browse all 707

Trending Articles